TRIM68 Antilichaam - C-terminalgebied: FITC (ARP34460_T100-FITC)

Tripartite motif containing 68

SS56, GC109, SS-56, RNF137

55128

Q96PF7

NP_060543

Human, Mouse, Rat, Cow, Horse, Pig

The immunogen is a synthetic peptide directed towards the C terminal region of human TRIM68

The protein encoded by TRIM68 contains a RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions. TRIM68 is expressed in many cancer cell lines. Its expression in normal tissues, however, was found to be restricted to prostate. TRIM68 was also found to be differentially expressed in androgen-dependent versus androgen-independent prostate cancer cells.

NLRP1; TFG; VIM; UBC; HSP90B1; HNRNPL; BTN1A1; UBE2D3; UBE2U; KAT5; AR

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

IHC, WB

0.5 mg/ml

Cow: 93%; Horse: 86%; Human: 100%; Mouse: 86%; Pig: 93%; Rat: 86%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

56kDa

Chang, G.T., et al., (2001) Eur. J. Cancer 37 (16), 2129-2134

Wet Ice

485

TRIM68

TRIM68

Rabbit

E3 ubiquitin-protein ligase TRIM68

NM_018073

RLRKGNEYRAGTDEYPILSLPVPPRRVGIFVDYEAHDISFYNVTDCGSHI